Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Immunocore Holdings plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
IMCR
Nasdaq
2836
www.immunocore.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Immunocore Holdings plc
Immunocore to present at upcoming investor conferences
- Nov 9th, 2026 5:00 am
Immunocore presents promising data from Phase 1/2 trial cohort evaluating brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma
- Nov 6th, 2026 10:00 am
Immunocore reports third quarter financial results and provides a business update
- Nov 6th, 2026 7:00 am
Immunocore will present Phase 1 data for brenetafusp plus KIMMTRAK® (tebentafusp-tebn) in metastatic uveal melanoma, during a late-breaking oral session at the 2026 SITC meeting
- Oct 29th, 2026 7:00 am
Should First Type 1 Diabetes Dosing Require Action From Immunocore Stock Investors?
- Oct 28th, 2026 6:14 pm
GeneDx Holdings And 2 Other Top Healthcare Stocks
- Oct 17th, 2026 9:11 am
Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes
- Oct 15th, 2026 5:00 am
Top 3 Healthcare Stocks To Watch In October 2026
- Oct 10th, 2026 8:17 am
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
- Sep 15th, 2026 9:22 am
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
- Sep 14th, 2026 5:00 am
Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?
- Aug 25th, 2026 9:07 am
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
- Aug 10th, 2026 9:39 am
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
- Aug 7th, 2026 11:27 am
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
- Aug 7th, 2026 7:55 am
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story
- Aug 7th, 2026 2:15 am
Immunocore Q2 Earnings Call Highlights
- Aug 6th, 2026 1:04 pm
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...
- Aug 6th, 2026 1:02 pm
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...
- Aug 6th, 2026 11:06 am
Immunocore reports second quarter financial results and provides a business update
- Aug 6th, 2026 5:00 am
Scroll